Most importantly, HCC patients presenting high FOXK2 protein expression exhibit worse survival in both uni- and multivariate analysis, pointing to FOXK2 as an independent predictor of poor prognosis in this type of cancer [49]. This evidence concerns the gene FOXK2 and hepatocellular carcinoma.